Skyward Specialty [SKWD] vs RLI [RLI] Detailed Stock Comparison
Skyward Specialty
NASDAQ
Loading...
RLI
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Skyward Specialty wins in 8 metrics, RLI wins in 10 metrics, with 0 ties. RLI appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Skyward Specialty | RLI | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 15.68 | 19.54 | Skyward Specialty |
| Price-to-Book Ratio | 2.23 | 3.62 | Skyward Specialty |
| Debt-to-Equity Ratio | 13.29 | 6.59 | RLI |
| PEG Ratio | 0.73 | 0.38 | RLI |
| EV/EBITDA | 9.97 | 14.94 | Skyward Specialty |
| Profit Margin (TTM) | 10.53% | 17.81% | RLI |
| Operating Margin (TTM) | 16.15% | 31.09% | RLI |
| EBITDA Margin (TTM) | 16.15% | 31.09% | RLI |
| Return on Equity | 16.26% | 19.49% | RLI |
| Return on Assets (TTM) | 2.81% | 4.47% | RLI |
| Free Cash Flow (TTM) | $300.89M | $555.51M | RLI |
| Dividend Yield | N/A | 3.21% | N/A |
| 1-Year Return | 24.46% | -9.41% | Skyward Specialty |
| Price-to-Sales Ratio (TTM) | 1.60 | 3.46 | Skyward Specialty |
| Enterprise Value | $1.78B | $6.26B | RLI |
| EV/Revenue Ratio | 1.42 | 3.45 | Skyward Specialty |
| Revenue per Share (TTM) | $31 | $20 | Skyward Specialty |
| Earnings per Share (Diluted) | $3.16 | $3.50 | RLI |
| Beta (Stock Volatility) | 0.61 | 0.61 | Skyward Specialty |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Skyward Specialty vs RLI Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Skyward Specialty | 0.24% | 3.90% | -7.36% | -18.04% | -2.09% | 1.04% |
| RLI | 0.23% | 2.79% | -1.58% | -7.46% | -8.40% | -15.99% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Skyward Specialty | 24.46% | 75.12% | -3.95% | -3.95% | -3.95% | -3.95% |
| RLI | -9.41% | 20.15% | 44.22% | 162.18% | 415.49% | 506.73% |
Performance & Financial Health Analysis: Skyward Specialty vs RLI
| Metric | SKWD | RLI |
|---|---|---|
| Market Information | ||
| Market Cap | $2.01B | $6.28B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 353,030 | 428,960 |
| 90 Day Avg. Volume | 433,613 | 708,453 |
| Last Close | $49.56 | $68.56 |
| 52 Week Range | $37.79 - $65.05 | $65.14 - $91.14 |
| % from 52W High | -23.81% | -24.78% |
| All-Time High | $65.05 (Jun 02, 2025) | $91.14 (Nov 25, 2024) |
| % from All-Time High | -23.81% | -24.78% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.20% |
| Quarterly Earnings Growth | 0.25% | 0.52% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.18% |
| Operating Margin (TTM) | 0.16% | 0.31% |
| Return on Equity (TTM) | 0.16% | 0.19% |
| Debt to Equity (MRQ) | 13.29 | 6.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $22.23 | $18.89 |
| Cash per Share (MRQ) | $8.67 | $1.49 |
| Operating Cash Flow (TTM) | $374.84M | $625.68M |
| Levered Free Cash Flow (TTM) | $-68,535,872 | $368.63M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 3.21% |
| Last 12-Month Dividend | $0.00 | $2.29 |
Valuation & Enterprise Metrics Analysis: Skyward Specialty vs RLI
| Metric | SKWD | RLI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 15.68 | 19.54 |
| Forward P/E | 15.16 | 10.72 |
| PEG Ratio | 0.73 | 0.38 |
| Price to Sales (TTM) | 1.60 | 3.46 |
| Price to Book (MRQ) | 2.23 | 3.62 |
| Market Capitalization | ||
| Market Capitalization | $2.01B | $6.28B |
| Enterprise Value | $1.78B | $6.26B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.42 | 3.45 |
| Enterprise to EBITDA | 9.97 | 14.94 |
| Risk & Other Metrics | ||
| Beta | 0.61 | 0.61 |
| Book Value per Share (MRQ) | $22.23 | $18.89 |
Financial Statements Comparison: Skyward Specialty vs RLI
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SKWD | RLI |
|---|---|---|
| Revenue/Sales | $320.80M | $407.67M |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $49.80M | $78.63M |
| Income Tax | $10.96M | $15.42M |
| Net Income (Profit) | $38.84M | $63.21M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SKWD | RLI |
|---|---|---|
| Cash & Equivalents | $112.92M | $27.06M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $76.55M | $100.00M |
| Total Shareholders Equity | $850.72M | $1.60B |
| Retained Earnings | $139.18M | $1.77B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SKWD | RLI |
|---|---|---|
| Operating Cash Flow | $96.76M | N/A |
| Capital Expenditures | $-202,000 | $-1.05M |
| Free Cash Flow | $96.56M | $102.46M |
| Debt Repayment | $0 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SKWD | RLI |
|---|---|---|
| Shares Short | 825,600 | 2.21M |
| Short Ratio | 1.85 | 2.79 |
| Short % of Float | 0.02% | 0.03% |
| Average Daily Volume (10 Day) | 353,030 | 428,960 |
| Average Daily Volume (90 Day) | 433,613 | 708,453 |
| Shares Outstanding | 40.13M | 91.74M |
| Float Shares | 37.43M | 79.72M |
| % Held by Insiders | 0.13% | 0.02% |
| % Held by Institutions | 1.02% | 0.85% |
Dividend Analysis & Yield Comparison: Skyward Specialty vs RLI
| Metric | SKWD | RLI |
|---|---|---|
| Last 12-Month Dividend | $0.00 | $2.29 |
| Last 12-Month Dividend Yield | N/A | 3.21% |
| 3-Year Avg Annual Dividend | $0.00 | $2.49 |
| 3-Year Avg Dividend Yield | N/A | 1.05% |
| 3-Year Total Dividends | $0.00 | $7.47 |
| Ex-Dividend Date | N/A | Feb 28, 2025 |